Top Cancer Stocks in Australia
Browse the largest Australia companies in the world ranked by their Market Capitalization. Global Cancer Companies in Australia market cap is $4.45B.
22 Jul 2024, 18:13 UTC
Companies: 11
🇦🇺1 |  | $11.12 | -3.52% | 3.46B | 66.68% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺2 |  | $0.28 | -1.16% | 250.62M | 21.43% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺3 |  | $0.04 | -1.67% | 246.32M | -46.36% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺4 |  | $0.09 | 8.33% | 60.90M | 8.33% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺5 |  | $0.16 | 9.09% | 50.91M | 108.70% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺6 |  | $0.37 | 0.00% | 34.36M | -16.30% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺7 |  | $0.00 | 11.11% | 21.21M | 0.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺8 |  | $0.05 | -6.02% | 15.06M | 5.41% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺9 |  | $0.01 | 0.00% | 10.87M | 0.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺10 |  | $0.02 | 13.64% | 10.79M | 25.00% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺11 |  | $0.00 | 0.00% | 6.52M | -44.44% | Underperform S&P500 YTD Benchamark | 🩹 Medical devices | - |
